Vital Signs - Specialty Generics - Next Wave of Generics Growth

Vital Signs - Specialty Generics - Next Wave of Generics Growth

 

RELEASE DATE
02-Apr-2007
REGION
North America
Research Code: 9561-00-2D-00-00
SKU: HC00477-NA-MR_03949
AvailableYesPDF Download
$1,500.00
In stock
SKU
HC00477-NA-MR_03949
$1,500.00
DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on April 2, 2007, provides a strategic overview of the potential for specialty generics in the pharmaceutical industry. Additionally, an emerging company profile is provided for Abrika Pharmaceuticals, an emerging specialty generic pharmaceuticals company. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of March 19 - March 23, 2007.

Table of Contents

This week's issue:

Related Research
This issue of Vital Signs, released on April 2, 2007, provides a strategic overview of the potential for specialty generics in the pharmaceutical industry. Additionally, an emerging company profile is provided for Abrika Pharmaceuticals, an emerging specialty generic pharmaceuticals company. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of March 19 - March 23, 2007.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-2D-00-00
Is Prebook No